  FDA  has named Virginia Behr as the Center for Drug Evaluation and Research (CDER, 

) ombudsman. Behr has been  with the agency since 1999 and before joining the FDA she worked at the  National Institutes of Health (NIH) and Uniformed Services   University of the Health  Sciences (USUHS) investigating the electrophysiological bases of stimulant drug  preference. Behr has been serving as the acting CDER ombudsman for the past  four months.

The  agency has also selected Edward Cox as director for the Office of Antimicrobial  Products (OAP). Cox has been serving as the acting director for OAP since  August of 2006. Cox graduated from the University  of North Carolina at Chapel   Hill and received his medical education at the University of North  Carolina School of Medicine. 

News

FDA has named Virginia Behr as the Center for Drug Evaluation and Research (CDER, www.fda.gov/cder/) ombudsman.